A 43-year-old man who developed numbness and impaired fine motor skills in his left arm lasting approximately 10 min while chanting during a football match, attended our emergency room. The patient, ...

The analysis wasn’t prespecified, and with no clear explanation, the field awaits insights from the larger BHF PROTECT-TAVI ...

天士力医药集团股份有限公司开发的全球首款异体脂肪间充质基质细胞（AD-MSCs）治疗 急性缺血性脑卒中 的药物（NR-20201），于2024年10月26日获得美国食品药品监督 管理 局（ FDA ）临床试验批准。

About The Study: The PROTECTED transcatheter aortic valve replacement (TAVR) trial could not show that the use of cerebral embolic protection (CEP) had a significant effect on the incidence of ...

The lawsuit is linked to Emboline’s embolic medical device, which is intended to offer protection from ischemic events.

The PROTECTED transcatheter aortic valve replacement (TAVR) trial could not show that the use of cerebral embolic protection (CEP ...

Extending the simple CT scan administered to all acute stroke patients to include the upper part of the heart increased ...

The CLEAR-IE registry data, which show clinical efficacy, are just the first step—an RCT may be forthcoming, researchers say.

Neurointerventional Device MarketThe global neurointerventional device market, valued at USD 2.6 billion in 2023, is ...

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of ...

A substantial insider sell was reported on November 7, by Ronda E Stryker, Board Member at Stryker SYK, based on the recent SEC filing. What Happened: According to a Form 4 filing with the U.S.